Age and new weight-loss drugs

Age and the new weight-loss drugs
Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?
Why your co-pay for weight loss drugs like Wegovy just went through the roof
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Obesity rates are down. Is that because of weight-loss drugs?
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and two dips in severe obesity rates. These falls were followed by steady increases in both categories.
Opinion
Biden Decision on Weight-Loss Drugs a Push-Back on Progressives
Last week, the Biden administration passed a rule allowing for the government healthcare programs Medicare and Medicaid coverage of a class of
Weight-Loss Drugs Saved Me From Alcoholism
Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating alcoholism and other addictions?
Prices on weight loss drugs are dropping — What patients need to know
Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr. Faith Coleman explains.
Where weight-loss drugs are popular in the U.S. in 2024
Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South with higher rates of obesity.
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some patients are finding a way around both of these concerns by experimenting with microdosing the drugs.
Why the New Weight Loss Drugs Don't Work for Some People
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don’t work for everyone. In tho
Are Weight-Loss Drugs Contributing to a Fall in the Obesity Rate?
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.
Force NHS to hand out weight-loss drugs, Blair think tank urges
The decision to limit Mounjaro injections to 220,000 people is ‘short-sighted and absurd’, says the former prime minister’s ...
Weight-loss drugs deliver life-changing health benefits - and big profits
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
‘Lifting from head to toe’: Weight-loss drugs boost popularity of surgeries to remove extra skin
Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used ...
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
New weight loss pharmacy opens in Marquette Township
The licensed pharmacy carries compounded Semaglutide and Tirzepatide, both of which are active ingredients in Ozempic and ...